Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jiaoyu Yi"'
Autor:
Liang Guo, Xuezhe Liu, Yao Wang, Jiaoyu Yi, Juanjuan Li, Yong Xu, Kaiyong Cai, Wufei Dai, Qian Feng, Bo Tao
Publikováno v:
Materials Today Bio, Vol 28, Iss , Pp 101208- (2024)
Artificial tracheal substitutes encounter significant challenges during long-segmental tracheal defects (LSTD) reconstruction, notably early postoperative anastomotic stenosis and tracheal chondromalacia. Mitigating early anastomotic stenosis by crea
Externí odkaz:
https://doaj.org/article/ce04d63bcf1148bea722d7d96959e850
Autor:
Linfei Hu, Jun Zhang, Mengran Tian, Ning Kang, Guangwei Xu, Jingtai Zhi, Xianhui Ruan, Xiukun Hou, Wei Zhang, Jiaoyu Yi, Weike Ma, Luchen Chang, Tao Tang, Xiangqian Zheng, Xi Wei, Ming Gao
Publikováno v:
Cell Death and Disease, Vol 13, Iss 2, Pp 1-14 (2022)
Abstract The use of the BRAF inhibitor vemurafenib exhibits drug resistance in the treatment of thyroid cancer (TC), and finding more effective multitarget combination therapies may be an important solution. In the present study, we found strong corr
Externí odkaz:
https://doaj.org/article/44e91cc7122543d3848a3cd9a42b5522
Autor:
Ying Sun, Wenjun Xie, Ning Kang, Jiaoyu Yi, Xianhui Ruan, Linfei Hu, Jingzhu Zhao, Xiangqian Zheng, Songfeng Wei, Ming Gao
Publikováno v:
Disease Markers. 2022:1-11
Quercetin, a flavonoid with anti-inflammatory and anticancer properties, is expected to be an innovative anticancer therapeutic agent for papillary thyroid carcinoma (PTC). However, the downstream signaling pathways that mediate quercetin-dependent a
Autor:
Xianhui Ruan, Jiaoyu Yi, Linfei Hu, Jingtai Zhi, Yu Zeng, Xiukun Hou, Jianfeng Huang, Pengfei Gu, Weijing Hao, Ming Gao, Yi Pan, Songfeng Wei, Xiangqian Zheng
Publikováno v:
Endocrine-related cancer. 29(2)
Increasing body of recent studies determining the expression of tumor-specific major histocompatibility complex (MHC) class II protein supports its potential role in several malignancies, but little is known in human medullary thyroid cancer (MTC). H
Autor:
Jingtai, Zhi, Jiaoyu, Yi, Xiukun, Hou, Wei, Wang, Weiwei, Yang, Linfei, Hu, Jianfeng, Huang, Shicheng, Guo, Xianhui, Ruan, Ming, Gao, Xiangqian, Zheng
Publikováno v:
Am J Cancer Res
Pharmacologic targeting of components of the MAPK/ERK pathway in differentiated thyroid carcinoma (DTC) is often limited due to the development of adaptive resistance. However, the detailed mechanism of MEK inhibitor (MEKi) resistance is not fully un
Autor:
Linfei Hu, Jun Zhang, Mengran Tian, Ning Kang, Guangwei Xu, Jingtai Zhi, Xianhui Ruan, Xiukun Hou, Wei Zhang, Jiaoyu Yi, Weike Ma, Luchen Chang, Tao Tang, Xiangqian Zheng, Xi Wei, Ming Gao
Publikováno v:
Cell Death and Disease, Vol 13, Iss 2, Pp 1-14 (2022)
The use of the BRAF inhibitor vemurafenib exhibits drug resistance in the treatment of thyroid cancer (TC), and finding more effective multitarget combination therapies may be an important solution. In the present study, we found strong correlations
Autor:
Jianfeng Huang, Xiukun Hou, Jingtai Zhi, Jiaoyu Yi, Ming Gao, Shicheng Guo, Linfei Hu, Xianhui Ruan, Xiangqian Zheng, Wei Wang, Weiwei Yang
Publikováno v:
SSRN Electronic Journal.
Background: Pharmacologic targeting of components of the MAPK/ERK pathway in differentiated thyroid carcinoma (DTC) is often limited due to the development of adaptive resistance. However, the detailed mechanism of MEK inhibitor (MEKi) resistance is
Autor:
Jingtai Zhi, Jiaoyu Yi, Xiukun Hou, Wei Wang, Weiwei Yang, Linfei Hu, Jianfeng Huang, Shicheng Guo, Xianhui Ruan, Xiangqian Zheng, Ming Gao
Background: Pharmacologic targeting of components of MAPK/ERK pathway in thyroid carcinoma is often limited due to the development of adaptive resistance. However, the detailed mechanism for MEK inhibitor (MEKi) resistance is not fully understood in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16059bdb25d3815f72b991c22e724e7b
https://doi.org/10.21203/rs.3.rs-86062/v1
https://doi.org/10.21203/rs.3.rs-86062/v1
Autor:
Jiefu Huang, Chuang Wang, Li Gao, Tianyu Zhang, Weijiao Yang, Ya Peng, Xuebao Xiang, Xiangfu Zhou, Jiaoyu Yi, Bo Tao, Yi Chen
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Fluorescence in situ hybridization (FISH) is used widely to detect cancer levels, but its value in urothelial carcinoma remains unclear. The aim of this study was to use FISH to examine the urine specimens of low-grade urothelial carcinoma
Autor:
Changzhao Huang, Lei Chen, Jiaoyu Yi, Wang Xu, Chao Qin, Yan Gao, Bo Tao, Ruiying Wang, Jincai Chen
Publikováno v:
Molecular Medicine Reports. 16:7553-7560
The aberrant proliferation of nucleus pulposus (NP) cells has been reported to be implicated in the pathogenesis of intervertebral disc degeneration (IDD). Previous studies have demonstrated that microRNAs (miRNAs), which are a group of small noncodi